Enovis Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Enovis Corp 公司

Enovis Corporation 是一家医疗技术公司。该公司专注于通过制造和分销医疗设备来开发临床差异化解决方案，其产品系列用于重建手术、康复、疼痛管理和物理治疗。该公司通过两个部门运营：预防与恢复和重建。预防与恢复部门开发、制造和分销刚性支撑产品、矫形软质产品、血管系统和压缩服装以及冷热疗法产品，并在临床康复和运动医学市场提供恢复科学产品，例如用于疼痛管理的骨骼生长刺激器和电刺激器。重建部门开发、制造和销售各种膝盖、臀部、肩膀、肘部、脚踝和手指植入物产品和手术生产力工具。该公司还提供 Novastep，一种微创手术 (MIS) 足部和踝关节解决方案。

公司简介

公司代码ENOV

公司名称Enovis Corp

上市日期May 08, 2008

成立日期1998

CEOMr. Damien Mcdonald

员工数量7367

证券类型Ordinary Share

年结日May 08

公司地址2711 Centerville Road

城市WILMINGTON

上市交易所NYSE Consolidated

国家United States of America

邮编19808

电话13022529160

网址https://www.enovis.com/

公司代码ENOV

上市日期May 08, 2008

成立日期1998

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

104.51K

+18.11%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

--

Mr. Terry D. Ross

Group President - Prevention and Recovery

36.11K

+90.73%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Ms. Barbara W. Bodem

Independent Director

10.52K

+168.36%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+168.36%

Mr. Philip A. Okala

Independent Director

--

Ms. Angela S. Lalor

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

104.51K

+18.11%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

--

Mr. Terry D. Ross

Group President - Prevention and Recovery

36.11K

+90.73%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

暂无数据

业务

地区

业务USD

名称

营收

占比

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

股东统计

更新时间: 7月10日周四

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.41%

The Vanguard Group, Inc.

10.64%

American Century Investment Management, Inc.

6.17%

Davenport Asset Management

5.38%

Dimensional Fund Advisors, L.P.

5.12%

Other

61.27%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.41%

The Vanguard Group, Inc.

10.64%

American Century Investment Management, Inc.

6.17%

Davenport Asset Management

5.38%

Dimensional Fund Advisors, L.P.

5.12%

Other

61.27%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

46.99%

Investment Advisor

45.59%

Hedge Fund

7.67%

Research Firm

4.24%

Individual Investor

1.55%

Bank and Trust

1.35%

Pension Fund

1.15%

Family Office

0.05%

Sovereign Wealth Fund

0.05%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

630

68.25M

119.48%

-3.27M

2025Q1

646

68.39M

119.73%

-3.70M

2024Q4

637

64.20M

113.02%

-5.55M

2024Q3

613

62.53M

111.92%

-6.94M

2024Q2

617

64.91M

118.38%

-5.04M

2024Q1

651

62.70M

114.40%

-9.13M

2023Q4

661

61.64M

112.95%

-6.99M

2023Q3

653

60.52M

110.96%

-10.76M

2023Q2

641

59.95M

109.96%

-8.07M

2023Q1

643

57.38M

105.33%

-9.99M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

6.52M

11.41%

+1.67M

+34.39%

Mar 31, 2025

The Vanguard Group, Inc.

6.08M

10.64%

-7.15K

-0.12%

Mar 31, 2025

American Century Investment Management, Inc.

3.52M

6.17%

+369.48K

+11.71%

Mar 31, 2025

Davenport Asset Management

3.07M

5.38%

-206.82K

-6.31%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.93M

5.12%

+27.89K

+0.96%

Mar 31, 2025

Royce Investment Partners

2.49M

4.36%

+20.23K

+0.82%

Mar 31, 2025

State Street Global Advisors (US)

1.89M

3.32%

+162.41K

+9.37%

Mar 31, 2025

Diamond Hill Capital Management Inc.

1.87M

3.28%

-918.91K

-32.92%

Mar 31, 2025

Hood River Capital Management LLC

1.44M

2.53%

+781.15K

+118.10%

Mar 31, 2025

River Road Asset Management, LLC

1.39M

2.44%

+153.53K

+12.40%

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

SPDR S&P Health Care Equipment ETF

1.7%

Invesco S&P SmallCap Health Care ETF

1.27%

Invesco S&P SmallCap 600 Pure Value ETF

0.53%

VictoryShares US Small Mid Cap Value Momentum ETF

0.3%

iShares S&P Small-Cap 600 Value ETF

0.29%

SPDR S&P 600 Small Cap Value ETF

0.28%

First Trust Small Cap Growth AlphaDEX Fund

0.28%

iShares U.S. Medical Devices ETF

0.2%

Avantis US Small Cap Equity ETF

0.2%

DFA Dimensional US Small Cap Value ETF

0.18%

SPDR S&P Health Care Equipment ETF

占比1.7%

Invesco S&P SmallCap Health Care ETF

占比1.27%

Invesco S&P SmallCap 600 Pure Value ETF

占比0.53%

VictoryShares US Small Mid Cap Value Momentum ETF

占比0.3%

iShares S&P Small-Cap 600 Value ETF

占比0.29%

SPDR S&P 600 Small Cap Value ETF

占比0.28%

First Trust Small Cap Growth AlphaDEX Fund

占比0.28%

iShares U.S. Medical Devices ETF

占比0.2%

Avantis US Small Cap Equity ETF

占比0.2%

DFA Dimensional US Small Cap Value ETF

占比0.18%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

公告日期

类型

比率

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Mar 18, 2022

Merger

3<1

Enovis Corp

26.280USD

Enovis Corp

26.280

概览

公司

财务